Savara Pharmaceuticals
SVRA
#6976
Rank
A$0.72 B
Marketcap
$4.20
Share price
0.00%
Change (1 day)
-42.65%
Change (1 year)

Earnings for Savara Pharmaceuticals (SVRA)

Earnings in 2024 (TTM): -A$0.13 Billion

According to Savara Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -A$85.42 Million a decrease over its 2022 earnings that were of -A$59.58 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Savara Pharmaceuticals from 2002 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$0.13 Billion44.17%
2023 -A$85.42 Million43.38%
2022 -A$59.58 Million-11.31%
2021 -A$67.17 Million-13.3%
2020 -A$77.48 Million-36.53%
2019 -A$0.13 Billion13.76%
2018 -A$0.11 Billion105.54%
2017 -A$52.21 Million34.11%
2016 -A$38.93 Million-37.43%
2015 -A$62.22 Million38.81%
2014 -A$44.82 Million33.62%
2013 -A$33.55 Million38.49%
2012 -A$24.22 Million24.59%
2011 -A$19.44 Million-36.5%
2010 -A$30.62 Million-3.14%
2009 -A$31.61 Million-23.28%
2008 -A$41.2 Million8.52%
2007 -A$37.97 Million-34.14%
2006 -A$57.65 Million184.43%
2005 -A$20.27 Million90.75%
2004 -A$10.63 Million190.35%
2003 -A$3.66 Million11.64%
2002 -A$3.28 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$28.36 Million-78.11%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.19 Billion 42.09%๐Ÿ‡บ๐Ÿ‡ธ USA